Trafalgar International (GCAN) EBITDA Margin (2017 - 2021)
Greater Cannabis Company (GCAN) posted quarterly EBITDA Margin of 494.65% for Q2 2021, down 32417.0% year-over-year from N/an in Q2 2020, and down 190.16% quarter-over-quarter from 170.47% in Q2 2020.
Trafalgar International (GCAN) EBITDA Margin (2017 - 2021) Analysis & Trends
Greater Cannabis Company's EBITDA Margin history runs 5 years deep, the most recent figure standing at 494.65% for Q2 2021.
- In Q2 2021, EBITDA Margin fell 32417.0% year-over-year to 494.65%; the TTM figure through Dec 2021 stood at 2716.91% (down 215651.0% YoY), while the FY2021 annual figure was 2716.91%, down 210402.0% from the prior year.
- EBITDA Margin for Q2 2021 stood at 494.65%, down from 170.47% in the prior quarter.
- The five-year high for EBITDA Margin was 99.52% in Q1 2018, with the low at 43656.16% in Q2 2017.
- The 5-year median for EBITDA Margin is 494.65% (2021), against an average of 8931.99%.
- The sharpest annual moves came in 2018 and 2019: EBITDA Margin soared 4375550 bps in 2018, then tumbled 423968 bps in 2019.
- Greater Cannabis Company's EBITDA Margin stood at 28856.62% in 2017, then soared by 100 bps to 87.65% in 2018, then tumbled by 4837 bps to 4327.33% in 2019, then soared by 96 bps to 170.47% in 2020, then sank by 190 bps to 494.65% in 2021.
- Business Quant data shows GCAN's EBITDA Margin at 494.65% in Q2 2021, 170.47% in Q2 2020, and 4327.33% in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -5.58% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 33.91% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 16.51% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 42.23% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 0.17% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 15.80% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 18.13% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Trafalgar International | 236,233.75 | 236,233.75 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | -494.65% |
| Jun 30, 2020 | -170.47% |
| Dec 31, 2019 | -4,327.33% |
| Sep 30, 2019 | -2,993.85% |
| Dec 31, 2018 | -87.65% |
| Jun 30, 2018 | 99.34% |
| Mar 31, 2018 | 99.52% |
| Sep 30, 2017 | -28,856.62% |
| Jun 30, 2017 | -43,656.16% |